{
  "module": "criteria",
  "method": "updateStudy",
  "body": {
    "_id": "60a5282e84a77822bd7ad195",
    "nct_id": "NCT00000123",
    "study_type": "Interventional",
    "trial_title": "The Berkeley Orthokeratology Study",
    "study_phase": "Phase 3",
    "prediatric_study": "Yes",
    "indication": "Astigmatism",
    "description": "The Berkeley Orthokeratology Study",
    "therapeutic_Area": "National Eye Institute (NEI)",
    "trial_alias": null,
    "molecule_name": null,
    "status": "In Progress",
    "createDate": "2021-05-19",
    "Therapeutic Area Average": {
      "name": "Therapeutic Area Average",
      "description": "Endocrinology, Type 2 Diabetes Phase 3 trails",
      "protocol_amendment_rate": "40%",
      "screen_failure_rate": "20%",
      "patient_burden": "61",
      "cost": "$18 - 21M"
    },
    "scenarios": [
      {
        "scenario_id": "1",
        "scenario_name": "scenario name 1",
        "scenario_description": "Fewer lab-based activities, broader range of allowable insulin types",
        "protocol_amendment_rate": "52%",
        "screen_failure_rate": "18%",
        "patient_burden": "40",
        "cost": "$15 - 20M",
        "Inclusion Criteria": {
          "Demographics": {
            "protocol_amendment_rate":"18%",
            "patient_burden":"52%",
            "Entities": [
            {
              "Eligibility Criteria": "Age",
              "Values": ">18",
              "Timeframe": "At least 3 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            },
            {
              "Eligibility Criteria": "Gender",
              "Values": "Men or nonpregnant women",
              "Timeframe": "At least 1 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            }
          ]}
        },
        "Exclusion Criteria": {
          "Demographics": [
            {
              "Eligibility Criteria": "Age",
              "Values": ">18",
              "Timeframe": "At least 3 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            },
            {
              "Eligibility Criteria": "Gender",
              "Values": "Men or nonpregnant women",
              "Timeframe": "At least 1 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            }
          ]
        },
        "Enrollment Feasibility": [
          {
            "name": "Age",
            "value": 500000,
            "description": "85% (52% Female/ 48% Male)"
          },
          {
            "name": "Gender",
            "value": 450000,
            "description": "75%"
          }
        ],
        "Schedule of Events": {}
      },
      {
        "scenario_id": "2",
        "scenario_name": "scenario name 2",
        "scenario_description": "More Lenient criteria, lab-based activities, broader range of allowable insulin types",
        "protocol_amendment_rate": "34%",
        "screen_failure_rate": "12%",
        "patient_burden": "53",
        "cost": "$23 - 27M",
        "Inclusion Criteria": {
          "Demographics": [
            {
              "Eligibility Criteria": "Age",
              "Values": "<48",
              "Timeframe": "At least 3 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            },
            {
              "Eligibility Criteria": "Gender",
              "Values": "Men or nonpregnant women",
              "Timeframe": "At least 1 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            }
          ]
        },
        "Exclusion Criteria": {
          "Demographics": [
            {
              "Eligibility Criteria": "Age",
              "Values": ">18",
              "Timeframe": "At least 3 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            },
            {
              "Eligibility Criteria": "Gender",
              "Values": "Men or nonpregnant women",
              "Timeframe": "At least 1 months prior to visit 1",
              "Condition Or Exception": "For Patients Taking Merbromin"
            }
          ]
        },
        "Enrollment Feasibility": [
          {
            "name": "Age",
            "value": 500000,
            "description": "85% (52% Female/ 48% Male)"
          },
          {
            "name": "Gender",
            "value": 450000,
            "description": "75%"
          }
        ],
        "Schedule of Events": {}
      }
    ]
  }
}